Cue Biopharma Inc Ret. on assets
What is the Ret. on assets of Cue Biopharma Inc?
The Ret. on assets of Cue Biopharma Inc is -82.85%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with ret. on assets similar to Cue Biopharma Inc
- Acorda Therapeutics Inc has Ret. on assets of -83.28%
- Dotz Nano has Ret. on assets of -83.20%
- Courbet Sa has Ret. on assets of -83.07%
- Canadian Orebodies has Ret. on assets of -83.05%
- NxGold has Ret. on assets of -83.04%
- China Environmental Technology has Ret. on assets of -82.87%
- Cue Biopharma Inc has Ret. on assets of -82.85%
- Loop Industries Inc has Ret. on assets of -82.70%
- Desktop Metal has Ret. on assets of -82.70%
- Gritstone Bio Inc has Ret. on assets of -82.53%
- NeuroVive Pharmaceutical AB has Ret. on assets of -82.51%
- Flow Beverage has Ret. on assets of -82.42%
- NOXXON Pharma NV has Ret. on assets of -82.39%